RxDoctor Payments Data

Aisha Rahman, MD

Interventional Pain Medicine · North Canton, OHNPI 1912196114

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.8% of the total across 79 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 15 manufacturers reported payments, led by Nevro Corp. at 27.7% of the total. Reporting peaked in 2023 at $816 and has fallen 53.2% since, to $382 in 2025. That places this record below the midpoint for interventional pain medicine clinicians in OH, where the typical reported total is $5,193.

$3,579in general payments, 2019–2025

Across 79 payments — averaging $45.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Nevro Corp.$990
  • Boston Scientific$942
  • Medtronic$775
  • Globus Medical$198
  • SPR Therapeutics, Inc$186
  • Abbott$122
  • plus $366 from 9 others

What the payments were for

  • Travel & lodging$60%
  • Food & beverage$3,573100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,579 in reported general payments places this provider in the 40th percentile of 67 interventional pain medicine providers in Ohio.

See all interventional pain medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$17,266
Medicare patients
46
Services billed
818

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Pregabalin187$3,636
Gabapentin265$3,461
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen99$2,100
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl13$1,904
Celecoxib40$1,234
Cyclobenzaprine Hcl52$1,156
Tizanidine Hcl107$1,098
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen63$896
Duloxetine Hcl21$512
Baclofen44$371
Tramadol Hcl66$349
Methocarbamol45$348
Nabumetone26$325
Topiramate51$257
Amitriptyline Hcl13$204

Paid to pharmacies, not to this prescriber.

Other interventional pain medicine in North Canton

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →